KEMET Displays Flex Mitigation Technology at Electronica 2010 in Munich

KEMET Corporation (NYSE Amex: KEM), a leading manufacturer of tantalum, ceramic, aluminum, film, paper and electrolytic capacitors, today announced that it will be featuring its Flex Mitigation technology this week at Electronica 2010 in Munich, Germany.

"KEMET Flex Mitigation technology has proven its worth by lowering the risk of board-flex failures," said Dr. Phil Lessner, KEMET Vice President and Chief Technology Officer. "With our recent addition of high voltage and tin/lead termination systems for critical applications, our expanded Flex Mitigation product line reinforces KEMET's commitment to offering the most complete line of capacitance solutions in the industry."

KEMET Flex Mitigation technology significantly reduces ceramic chip failures due to flex cracks, the primary failure mode of multilayer ceramic capacitors (MLCCs). This technology decreases the probability of a low IR or short circuit condition when forced to failure in a board stress flex situation.

Driven by the demand for more reliable components, Flex Mitigation capacitors are designed for applications where higher operating temperatures or mechanical stress are concerns. Any application in the consumer, medical, industrial (power supply), military/aerospace and telecom markets can benefit from this technology. Additionally, all KEMET Flex Mitigation products are AEC-Q200 certified for automotive applications.

The KEMET Flex Mitigation portfolio includes Open Mode, Floating Electrode (FE-CAP), Flexible Termination (FT-CAP), Floating Electrode with Flexible Termination (FF-CAP) and KEMET Power Solutions (KPS).

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.